CLINICAL EFFECTS OF A NEW ANTI-ANGINAL AGENT, PRENYLAMINE (SEGONTIN)

被引:6
|
作者
BAUMGARTEN, A
机构
关键词
D O I
10.5694/j.1326-5377.1962.tb26023.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:429 / &
相关论文
共 50 条
  • [1] CLINICAL-STUDY OF NEW ANTI-ANGINAL AGENT - TIMOLD MALEATE
    WAREMBOURG, H
    GINESTET, A
    CARRE, A
    LILLE MEDICAL, 1977, 22 (04): : 280 - 285
  • [2] EFFECTS OF BEPRIDIL, A NEW ANTI-ANGINAL AGENT, ON AMBULATORY ELECTROCARDIOGRAPHY IN HUMAN VOLUNTEERS
    DUCHENEMARULLAZ, P
    KANTELIP, JP
    TROLESE, JF
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) : 506 - 510
  • [3] ANTI-ANGINAL EFFECTS OF CLONIDINE
    THOMAS, MG
    QUIROZ, AC
    SANDER, GE
    GILES, TD
    CLINICAL RESEARCH, 1984, 32 (05): : A862 - A862
  • [4] ANTI-ANGINAL EFFECTS OF PROPRANOLOL AND NIFEDIPINE
    DARGIE, HJ
    LYNCH, PG
    KRIKLER, DM
    KRIKLER, S
    BRITISH HEART JOURNAL, 1980, 43 (06): : 724 - 724
  • [5] ANTI-ANGINAL DRUGS
    GOLDBARG, A
    PAXINOS, J
    MILLER, RR
    POSTGRADUATE MEDICAL JOURNAL, 1970, 46 (532) : 94 - &
  • [6] HEMODYNAMIC EFFECTS OF A NEW ANTI-ANGINAL DRUG, DILTIAZEM HYDROCHLORIDE
    KUSUKAWA, R
    KINOSHITA, M
    SHIMONO, Y
    TOMONAGA, G
    HOSHINO, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1977, 27-1 (04): : 878 - 883
  • [7] ASSESSMENT OF ANTI-ANGINAL EFFECT OF TOLAMOLOL, A NEW BETA-BLOCKING AGENT
    WILLIAMS, A
    HOLT, MC
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1975, 3 (06) : 399 - 406
  • [8] The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent
    McCarthy, Cian P.
    Mullins, Kieran V.
    Kerins, David M.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (04) : 266 - 272
  • [9] New class of anti-anginal treatment launched
    不详
    IRISH MEDICAL JOURNAL, 1998, 91 (01) : 30 - 30
  • [10] BEPRIDIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY AS AN ANTI-ANGINAL AGENT WITH ANTI-ARRHYTHMIC PROPERTIES
    ALPERT, JS
    COUMEL, P
    GREEFF, K
    KRIKLER, DM
    REMME, WJ
    SCHONBAUM, E
    VERDUYN, CW
    PHARMATHERAPEUTICA, 1985, 4 (04) : 195 - 222